Karin Fijnvandraat

Professor of Pediatric Hematology
Department of Pediatric Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

Presentation(s):

• OC 08.4 - Predictive risk factors for recurrent VTE in children

  Saturday, July 9, 2022
  1:45 PM – 2:00 PM

• OC 27.5 - Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B (OPTI-CLOT TARGET study) – Preliminary results

  Sunday, July 10, 2022
  3:45 PM – 4:00 PM

• OC 47.2 - Prevalence and characteristics of non-neutralizing FVIII-specific antibodies in persons with hemophilia A – preliminary results

  Monday, July 11, 2022
  3:00 PM – 3:15 PM

• PB0652 - Transition readiness among Dutch adolescents and young adults with haemophilia: a questionnaire study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0797 - Restoration of VWF in Von Willebrand Disease type 3 canine ECFCs through CRISPR-Cas9 mediated gene editing

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 63.4 - Little discrepancy of one-stage and chromogenic assays in a large international cohort of patients with non-severe hemophilia A and B (DYNAMO study)

  Tuesday, July 12, 2022
  3:30 PM – 3:45 PM

• PB1127 - Novel accreditation of European haemophilia treatment and gene therapy centres

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1146 - Determinants of successful immune tolerance induction in persons with hemophilia A – systematic review and meta-analysis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM